microRNA Profile in Umbilical Cord Blood NK Cells
NCT00751569 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2008-09-12
Summary
Umbilical cords contain immature blood cells, including a group of lymphocytes, that are important in the so-called natural immunity. We want to study the cytokine levels in umbilical cord NK cells and its regulation a family of newly identified small RNAs (microRNAs).
Conditions
- Pregnant Women
Interventions
- OTHER
-
blood donation
obtaining cord blood
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Chung-Wu Lin · National Taiwan University
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-09-30
- Completion
- 2009-09-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Transcriptomics Signature of Anti Vaccinia Memory B Cells
NCT02556489 ·Status: UNKNOWN
-
NK Cells Infusion for Advanced Malignancies
NCT03619954 ·Status: UNKNOWN ·Phase: PHASE1
-
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
NCT00173290 ·Status: UNKNOWN
-
Autologous Decidual-like Natural Killer Cells Therapy for Reproductive Failure
NCT07230574 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Hyporesponsiveness of Natural Killer Cells and a Dysfunctional Inflammatory Response in Critically Ill Patients
NCT02565589 ·Status: COMPLETED
-
Assessment of Blood and Follicular Fluid Immune Cell Constitution in Patients Undergoing in Vitro Fertilization
NCT01083745 ·Status: UNKNOWN
-
Age-matched Reference Values for Circulating Natural Killer T-like Cells
NCT06450743 ·Status: COMPLETED ·Phase: NA
-
The Role of NK Cells to Detect Blood Infection in ALL.
NCT06160115 ·Status: NOT_YET_RECRUITING
-
Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation
NCT01795378 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
NCT01915992 ·Status: UNKNOWN ·Phase: NA
-
Sequencing T-cells in Type I Diabetes Mellitus
NCT02040337 ·Status: COMPLETED
-
Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD
NCT06568328 ·Status: RECRUITING ·Phase: PHASE1
-
Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors
NCT05976906 ·Status: UNKNOWN ·Phase: PHASE1
-
Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy
NCT03325036 ·Status: COMPLETED
-
A Therapeutic Protocol in Previous Failed ART Patients With High Total NK Cells
NCT03792997 ·Status: COMPLETED ·Phase: PHASE2
-
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
NCT03207854 ·Status: RECRUITING
-
Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation
NCT02978274 ·Status: UNKNOWN
-
The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell Expression
NCT00854282 ·Status: UNKNOWN ·Phase: NA
-
Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection
NCT01914263 ·Status: UNKNOWN ·Phase: PHASE1
-
A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes
NCT05371730 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients
NCT01046227 ·Status: UNKNOWN
-
Lymphocytes Subpopulation in Cancer Patients
NCT02516371 ·Status: UNKNOWN ·Phase: NA
-
Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
NCT06842407 ·Status: RECRUITING
-
NK Cell Infusion for Patients With Acute Myeloid Leukemia
NCT04221971 ·Status: UNKNOWN ·Phase: PHASE1
-
Prospective Study of White Blood Cells
NCT04838171 ·Status: RECRUITING